Clinical Trial

Effects of P24 on Postprandial Aminoacidemia

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to quantify the acute effects of an acid-active protease enzyme supplement (P24) on postprandial aminoacidemia following consumption of a standardized mixed-protein meal containing both plant- and animal-derived protein sources. Secondary objectives include evaluating the postprandial plasma peptidomic response, characterizing the postprandial hormonal responses (GLP-1, insulin, and GIP), and assessing the postprandial glucose response using standardized capillary blood glucose measurements. The study will also evaluate subjective responses including satiety and hunger and gastrointestinal symptoms.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-08-08
notable Primary completion pushed: 2026-12-15 -> 2027-03-31 2026-08-08
Trial Details
NCT Number NCT07479173
Lead Sponsor Amplifye
Conditions Postprandial Amino Acid Concentrations in Healthy Adults
Enrollment 30 participants
Start Date 2026-08-17
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-08-07